STEINMAN LAWRENCE

STEINMAN LAWRENCE, Director, has filed 3 insider trading reports covering 2 companies. Total disclosed trading volume is $273.7K. The predominance of buying activity ($100.0K in purchases vs. $0 in sales) may reflect this insider's confidence in the underlying companies. The largest single filing involves Pasithea Therapeutics Corp. (KTTA). All transactions sourced from SEC Form 4 filings.